These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. Davis HF; Skolasky RL; Selnes OA; Burgess DM; McArthur JC AIDS Read; 2002 Jan; 12(1):29-31, 38. PubMed ID: 11862658 [TBL] [Abstract][Full Text] [Related]
3. Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalus. van Harten B; Courant MN; Scheltens P; Weinstein HC Dement Geriatr Cogn Disord; 2004; 18(1):109-14. PubMed ID: 15087586 [TBL] [Abstract][Full Text] [Related]
4. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy. Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172 [TBL] [Abstract][Full Text] [Related]
5. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. Ganasen KA; Fincham D; Smit J; Seedat S; Stein D J Neurol Sci; 2008 Jun; 269(1-2):62-4. PubMed ID: 18237748 [TBL] [Abstract][Full Text] [Related]
6. The HIV Dementia Scale: predictive power in mild dementia and HAART. Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212 [TBL] [Abstract][Full Text] [Related]
7. Spanish validation of the HIV dementia scale in women. Wojna V; Skolasky RL; McArthur JC; Maldonado E; Hechavarria R; Mayo R; Selnes O; Ginebra T; de la Torre T; Garcia H; Kraiselburd E; Melendez-Guerrero LM; Zorrilla CD; Nath A AIDS Patient Care STDS; 2007 Dec; 21(12):930-41. PubMed ID: 18154490 [TBL] [Abstract][Full Text] [Related]
8. HIV Dementia Scale and psychomotor slowing--the best methods in screening for neuro-AIDS. von Giesen HJ; Haslinger BA; Rohe S; Köller H; Arendt G J Neuropsychiatry Clin Neurosci; 2005; 17(2):185-91. PubMed ID: 15939972 [TBL] [Abstract][Full Text] [Related]
9. Detecting HIV associated neurocognitive disorders in adolescents: what is the best screening tool? Lyon ME; McCarter R; D'Angelo LJ J Adolesc Health; 2009 Feb; 44(2):133-135. PubMed ID: 19167661 [TBL] [Abstract][Full Text] [Related]
10. Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients. Janssen MA; Bosch M; Koopmans PP; Kessels RP J Neurovirol; 2015 Aug; 21(4):383-90. PubMed ID: 25678141 [TBL] [Abstract][Full Text] [Related]
11. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale. Morgan EE; Woods SP; Scott JC; Childers M; Beck JM; Ellis RJ; Grant I; Heaton RK; J Clin Exp Neuropsychol; 2008 Jan; 30(1):83-90. PubMed ID: 17852582 [TBL] [Abstract][Full Text] [Related]
12. Validity of two scales in identifying HIV-associated dementia. Berghuis JP; Uldall KK; Lalonde B J Acquir Immune Defic Syndr; 1999 Jun; 21(2):134-40. PubMed ID: 10360805 [TBL] [Abstract][Full Text] [Related]
13. The International HIV Dementia Scale: a new rapid screening test for HIV dementia. Sacktor NC; Wong M; Nakasujja N; Skolasky RL; Selnes OA; Musisi S; Robertson K; McArthur JC; Ronald A; Katabira E AIDS; 2005 Sep; 19(13):1367-74. PubMed ID: 16103767 [TBL] [Abstract][Full Text] [Related]
14. HIV-Dementia Scale as a screening tool for the detection of subcortical cognitive deficits: validation of the Italian version. Montanucci C; Chipi E; Salvadori N; Rinaldi R; Eusebi P; Parnetti L J Neurol; 2021 Dec; 268(12):4789-4795. PubMed ID: 33991241 [TBL] [Abstract][Full Text] [Related]
15. Limitations of the International HIV Dementia Scale in the current era. Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V; AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa. Goodkin K; Hardy DJ; Singh D; Lopez E J Neuropsychiatry Clin Neurosci; 2014; 26(4):352-8. PubMed ID: 26037857 [TBL] [Abstract][Full Text] [Related]
17. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study. McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286 [TBL] [Abstract][Full Text] [Related]
18. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. Sakamoto M; Marcotte TD; Umlauf A; Franklin D; Heaton RK; Ellis RJ; Letendre S; Alexander T; McCutchan JA; Morgan EE; Woods SP; Collier AC; Marra CM; Clifford DB; Gelman BB; McArthur JC; Morgello S; Simpson D; Grant I; J Acquir Immune Defic Syndr; 2013 Jan; 62(1):36-42. PubMed ID: 23111573 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of the HIV dementia scale and the international HIV dementia scale in screening for HIV-associated neurocognitive disorders among Spanish-speaking adults. López E; Steiner AJ; Smith K; Thaler NS; Hardy DJ; Levine AJ; Al-Kharafi HT; Yamakawa C; Goodkin K Appl Neuropsychol Adult; 2017; 24(6):512-521. PubMed ID: 27712132 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. Haddow LJ; Floyd S; Copas A; Gilson RJ PLoS One; 2013; 8(4):e61826. PubMed ID: 23613945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]